Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Smajic Edin |

Presentations at scientific and public conferences

Mader, JK; Donsa, K; Aberer, F; Lichtenegger, K; Lanz, C; Smajic, E; Hoell, B; Beck, P; Pieber, TR; Plank, J Increase in time in target when using a basal-bolus algorithm for Insulin dosing with insulin glargine U300 during hospital stay.
Endocrine Abstracts. 2017; 49: -19th European Congress of Endocrinology (ECE); MAY 20-23, 2017; Lisbon, PORTUGAL. [Poster]
FullText

Mader, JK; Donsa, K; Aberer, F; Lichtenegger, KM; Lanz, C; Smajic, E; Hoell, B; Beck, P; Pieber, TR; Plank, J Increase in Time in Target when Using a Basal-Bolus Algorithm for Insulin Dosing with insulin glargine U300 during Hospital Stay.
4th International Hospital Diabetes Meeting; MAY 19-20, 2017; Atlanta, USA. 2017. [Poster]

Mader, JK; Donsa, K; Aberer, F; Smajic, E; Lanz, C; Lichtenegger, KM; Spat, S; Hoell, B; Beck, P; Pieber, TR; Plank, J GlucoTab-based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using an Ultra-Long-Acting Insulin Analog.
Diabetes. 2017; 66(S1):A277-A277.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA. [Poster]

Mader, JK; Donsa, K; Aberer, F; Smajic, E; Lichtenegger, KM; Hoell, B; Beck, P; Pieber, TR; Plank, J Algorithm based basal-bolus insulin therapy for inpatient glycaemic control using a novel long acting insulin analogue.
International Diabetes Federation (IDF) Congress; DEC 4-8, 2017; Abu Dhabi, UNITED ARAB EMIRATES. 2017. [Poster]

Mader, JK; Donsa, K; Aberer, F; Smajic, E; Lichtenegger, KM; Lanz, C; Holl, B; Beck, P; Pieber, TR; Plank, J GlucoTab((R))-based Basic Bolus Insulin Therapy with Insulin glargin U300 increases the Time in the Target Area in hospitalized Female Patients with Type 2 Diabetes mellitus
WIEN KLIN WOCHENSCHR. 2017; 129: 171-171. [Poster]
Web of Science

Mader, JK; Donsa, K; Aberer, F; Smajic, E; Lichtenegger, KM; Lanz, C; Höll, B; Beck, P; Pieber, TR; Plank, J GlucoTab®-basierte Basis-Bolus Insulintherapie mit Insulin glargin U300 erhöht die Zeit im Zielbereich bei hospitalisierten PatientInnen mit Diabetes mellitus Typ 2
Wiener klinische Wochenschrift, Ausgabe 129 (Suppl. 4) . 2017; 171-171.-45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18; Salzburg. [Oral Communication]